World class leadership

Our pioneering founders, Experienced senior management team, and diverse board of directors comprise a virtual who’s who of scientific innovators, battle-tested executives and highly skilled directors.

Biotech Company Red Icon

Pioneering Founders

Biotech Company Co-Founder

Prof Sir Marc Feldman
Co-Founder

  • Pioneer of anti-TNF therapy, world’s biggest drug class ($40B/yr)
  • Anti-TNF discovery of Remicade eventually led to Centocor’s acquisition by J&J for $4.9B
  • International awards for biomedical innovations: Crafoord, Lasker, Canada Gairdner, Janssen, EU Inventor of the Year, Tang
  • UK and Australian knighthood
  • Fellow of Royal Society and Australian Academy of Science; member of National Academy of Sciences
Biotech Company Co-Founder

Prof Lawrence Steinman
Co-Founder; Director

  • Discovered role of integrins, which led to natalizumab (Tysabri, sold to Biogen for $3.25B), a highly effective treatment for MS and IBD
  • Founder of Neurocrine Biosciences
  • Board member of Centocor, sold to J&J for $4.9B
  • International awards for biomedical innovations: Sasse, Dystel, Charcot, Cerami, Javits (twice)
  • Member of National Academy of Medicine and National Academy of Sciences
Biotech Company Co-Founder

Prof Jagdeep Nanchahal, MD, PhD
Co-Founder; Chairman of Clinical Advisory Board

  • Pioneered the treatment of fibrosis of the hand (Dupuytren’s disease) by identifying TNF⍺ as a target
  • Surgeon-scientist, leading Phase 2b/3 trial for Dupuytren’s disease funded by Wellcome Trust and UK Dept. of Health
  • Fellow of the Royal College of PlasticSurgeons

Experienced Senior Management Team

Blair Jordan, MBA, LL.B
Interim CEO

Biotech Company CFO

Ozan Pamir
CFO